Recent research have converged on the intersection of GLP|GIP|GCGR agonist therapies and DA communication. While GCGR agonists are increasingly employed for treating type 2 T2DM, their emerging impacts on motivation https://tirzepatide171688.laowaiblog.com/40525833/emerging-glp-agonists-and-dopamine-modulation-a-contextual-examination